The successful integration of omics-based personalised medicine into clinical practice does not only require the demonstration of its clinical utility and cost-effectiveness but also the development of processes so that the relevant information is available to the correct health practitioner at the appropriate time. This is particularly important as the routine availability of whole genome sequences becomes a reality. In conjunction with education, research in clinical bioinformatics needs to be undertaken as to how such vast data can be appropriately presented. In addition and to further advance personalised medicine the European Commission should promote evidence-based multidisciplinary training of omics.
